UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 04/2016, Volume 315, Issue 15, pp. 1580 - 1590
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Myalgia - blood | Myalgia - chemically induced | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Myositis - chemically induced | Hypercholesterolemia - drug therapy | Myositis - prevention & control | Time Factors | Adult | Cholesterol, LDL - blood | Female | Muscular Diseases - prevention & control | Ezetimibe - therapeutic use | Muscular Diseases - chemically induced | Atorvastatin Calcium - adverse effects | Hypercholesterolemia - blood | Myalgia - prevention & control | Creatine Kinase - blood | Double-Blind Method | Ezetimibe - adverse effects | Biomarkers - blood | Myositis - blood | Anticholesteremic Agents - adverse effects | Muscular Diseases - blood | Rhabdomyolysis - prevention & control | Cross-Over Studies | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Rhabdomyolysis - chemically induced | Rhabdomyolysis - blood | Clinical trials | Cholesterol, LDL | Usage | Care and treatment | Side effects | Muscular system | Comparative analysis | Drug therapy | Low density lipoprotein | Statins | Index Medicus | Abridged Index Medicus
Journal Article
The American heart journal, ISSN 0002-8703, 2010, Volume 159, Issue 5, pp. 705 - 709
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Simvastatin - therapeutic use | Humans | Treatment Outcome | Models, Statistical | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cholesterol, LDL - blood | Ezetimibe, Simvastatin Drug Combination | Patient Compliance | Research Design | Drug Combinations | Studies | Nonprofit organizations | Bias | Lipids | Drug therapy | Pharmaceutical industry | Acute coronary syndromes | Patients | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 02/2019, Volume 393, Issue 10170, pp. 407 - 415
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Aged | Age Factors | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Randomized Controlled Trials as Topic | Blood circulation disorders | Coronary artery bypass | Analysis | Cardiac patients | Low density lipoproteins | Trans fatty acids | Statins | Cardiovascular agents | Heart | Lipoproteins (low density) | Clinical trials | Risk | Evidence-based medicine | Incidence | Heterogeneity | Randomization | Reduction | Vascular diseases | Older people | Patient safety | Safety | Heart diseases | Age | Medical research | Stroke | Data analysis | Statistical analysis | Mortality | Patients | Disease control | Cholesterol | Meta-analysis | Renal failure | Dialysis | Health risk assessment | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
The American heart journal, ISSN 0002-8703, 07/2020, Volume 225, pp. 3 - 9
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Critical Pathways - organization & administration | Pandemics | United States | Humans | Heart Failure - physiopathology | Coronavirus Infections - physiopathology | Patient Care Management - methods | Infection Control - methods | Arrhythmias, Cardiac - physiopathology | Heart Diseases - virology | COVID-19 | Heart Failure - therapy | Infection Control - organization & administration | SARS-CoV-2 | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Pneumonia, Viral - complications | Coronavirus Infections - complications | Heart Failure - diagnosis | Heart Failure - etiology | Arrhythmias, Cardiac - therapy | Betacoronavirus - isolation & purification | Heart Diseases - physiopathology | Pneumonia, Viral - therapy | Arrhythmias, Cardiac - etiology | Pneumonia, Viral - physiopathology | Heart Diseases - diagnosis | Heart Diseases - therapy | Coronavirus Infections - therapy | Evidence-Based Practice - trends | Arrhythmias, Cardiac - diagnosis | Critical Pathways - standards | Complications and side effects | Coronaviruses | Cardiology | Analysis | Severe acute respiratory syndrome | Cardiovascular system | Resource utilization | Medical imaging | Complications | Mortality | Viral diseases | Resource availability | Cardiovascular disease | Infections | Resources utilization | Severe acute respiratory syndrome coronavirus 2 | Respiratory diseases | Heart diseases | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2016, Volume 67, Issue 13, pp. 484 - 484
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2017, Volume 69, Issue 8, pp. 911 - 921
Cardiovascular | Internal Medicine | simvastatin | acute coronary syndrome | risk stratification | secondary prevention | ezetimibe | low-density lipoprotein cholesterol | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Simvastatin - therapeutic use | Prospective Studies | Risk Assessment | Humans | Middle Aged | Male | Treatment Outcome | Secondary Prevention | Acute Coronary Syndrome - complications | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Acute Coronary Syndrome - therapy | Female | Aged | Ezetimibe - therapeutic use | Myocardial Infarction - prevention & control | Medical colleges | Continuing medical education | Cardiology | Coronary heart disease | Medicine, Preventive | Statins | Cardiovascular agents | Preventive health services | Prevention | Medical research | Low density lipoproteins | Medicine, Experimental | Hypertension | Heart failure | Stroke | Heart attacks | Cardiovascular disease | Lipids | Angina pectoris | Low density lipoprotein | Patients | Cholesterol | Disease prevention | Coronary vessels | Electrocardiography | Population | Diabetes | Kidney diseases | Health risk assessment | Acute coronary syndromes | Age | Index Medicus | Abridged Index Medicus
Journal Article
The American heart journal, ISSN 0002-8703, 2014, Volume 168, Issue 2, pp. 205 - 212.e1
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Simvastatin - therapeutic use | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Ezetimibe | Cholesterol, LDL - drug effects | Male | Azetidines - pharmacology | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Cardiovascular Diseases - epidemiology | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Anticholesteremic Agents - pharmacology | Medical research | Low density lipoproteins | Simvastatin | Cardiac patients | Medicine, Experimental | Coronary heart disease | Antilipemic agents | Heart attacks | Acute coronary syndromes | Drug therapy | Cholesterol | Statins | Index Medicus | Abridged Index Medicus
Journal Article
European heart journal, ISSN 0195-668X, 12/2018, Volume 39, Issue 48, pp. 4255 - 4256
Journal Article
The American heart journal, ISSN 0002-8703, 2008, Volume 156, Issue 5, pp. 826 - 832
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | Myocarditis. Cardiomyopathies | Medical sciences | Coronary heart disease | Acute Coronary Syndrome - drug therapy | Simvastatin - therapeutic use | Multicenter Studies as Topic | Azetidines - therapeutic use | Double-Blind Method | Simvastatin - administration & dosage | Anticholesteremic Agents - administration & dosage | Humans | Treatment Outcome | Ezetimibe, Simvastatin Drug Combination | Drug Combinations | Care and treatment | Cardiac patients | Patient outcomes | Simvastatin | Low density lipoproteins | Clinical trials | Comparative analysis | Cholesterol | Heart attacks | Acute coronary syndromes | Drug therapy | Index Medicus | Abridged Index Medicus | MEDICIN OCH HÄLSOVETENSKAP | MEDICAL AND HEALTH SCIENCES
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 06/2011, Volume 305, Issue 24, pp. 2556 - 2564
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Diabetes. Impaired glucose tolerance | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Dose-Response Relationship, Drug | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Cardiovascular Diseases - prevention & control | Diabetes Mellitus - epidemiology | Humans | Cardiovascular Diseases - epidemiology | Risk | Odds Ratio | Randomized Controlled Trials as Topic | Clinical trials | Diabetes | Drug therapy | Drug dosages | Statins | Meta-analysis | Index Medicus | Abridged Index Medicus
Journal Article